Analysis of Patient Education Guides Generated by ChatGPT and Gemini on Common Anti-diabetic Drugs: A Cross-Sectional Study

Introduction Patient information guides are required, as they help to identify early diseases and complications and to prevent them. Artificial intelligence (AI) tools are being used to create patient education guides for easy accessibility to people. Methodology This was a cross-sectional study analyzing patient information guides regarding six anti-diabetic drugs created using ChatGPT (OpenAI, Inc., San Francisco, California, United States) and Gemini (Google LLC, Mountain View, California, United States), respectively. The patient information guides were on anti-diabetic drugs, including metformin, empagliflozin, liraglutide, glipizide, sitagliptin, and insulin glargine, and were created with the help of various prompts. Results There was no statistically significant difference found between any of the characteristics of the responses generated by the two AI tools, according to the P values obtained. Conclusion On comparing the two AI tools, there was not much difference noted in readability, reliability, and similarity.